clinical trials

Recent Rosacea Blog Posts

The recruiting manager from Frontage Clinical is looking for participants in the trial they are hosting for rosacea redness. Frontage Clinical in Hackensack, NJ is conducting a research study to evaluate the safety of an investigational topical gel medication for moderate to severe facial redness associated with ROSACEA. All qualified participants will receive at no […]

Continue Reading

Hot on the trail of the Phase 1 Study Results and Funding Announcement is a listing confirming that Vicept Therapeutics are soon to start dose finding trials for the treatment of the redness of rosacea. The trial will study the efficacy of V-101 Cream, applied once per day, at a low dose of 0.01%, 2 […]

Continue Reading

With this latest press release, Vicept Therapeutics is now well and truly out in the public view, and attracting interest from rosacea sufferers. This release of results for Phase I trials of V-101 comes after news that Vicept Therapeutics had secured funding for the development of V-101. Now that a company name has surfaced we […]

Continue Reading

Foamix to Trial Foaming Topical Minocycline (FMX103)

The prescription topical market for rosacea seems to be somewhat crowded. Sufferers have the choice of the metrogel family, finacea as well as the potential to try acne topicals such as retinoids. So far there hasn’t been a proven topical anti-biotic per se. Metrogel and Finacea have anti-inflammatory properties, but are not classified as anti-biotics. […]

Continue Reading

Atralin Gel (Tretinoin 0.05%) being trialled for the redness of Rosacea

The Clinical Trials Register is listing a new trial today for a topical retinoid, Atralin Gel 0.05% for the treatment of the redness and broken blood vessels of rosacea. Officially the trial will look at the redness, telangiectasia, facial edema, and dry skin of around 80 rosacea sufferers over a period of up to 46 […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.